Related Experiment Video
Updated: Mar 9, 2026

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
Viral reverse transcriptases
Luis Menéndez-Arias1, Alba Sebastián-Martín1, Mar Álvarez1
1Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, c/Nicolás Cabrera, 1, Campus de Cantoblanco, 28049 Madrid, Spain.
Reverse transcriptases (RTs) are key viral enzymes crucial for replication across five families. Understanding their structure and dual activities aids in developing new antiviral therapies, particularly for HIV and Hepatitis B.
Area of Science:
- Molecular Biology
- Virology
- Enzymology
Background:
- Reverse transcriptases (RTs) are essential enzymes for the replication of viruses in the Retroviridae, Metaviridae, Pseudoviridae, Hepadnaviridae, and Caulimoviridae families.
- RTs possess DNA polymerase and ribonuclease H activities, critical for converting RNA into DNA and integrating it into host genomes.
- These enzymes are known for high error rates and low processivity, contributing to viral mutation and recombination.
Purpose of the Study:
- To review current knowledge on reverse transcription mechanisms in five major virus families.
- To summarize available biochemical and structural data on reverse transcriptases.
- To discuss the potential for inhibiting RT enzymatic activities for therapeutic purposes.
Main Methods:
- Literature review of scientific publications on reverse transcriptases and reverse transcription.
- Analysis of structural and biochemical data from studies on various RT enzymes.
- Synthesis of information regarding the enzymatic activities, biosynthesis, and inhibition of RTs.
Main Results:
- RTs exhibit diverse quaternary structures (monomers, homodimers, heterodimers) and play distinct roles in viral replication cycles.
- Inhibition of HIV-1 RT polymerase activity is central to current antiretroviral therapy, highlighting the therapeutic potential of targeting RTs.
- Limited structural and biochemical data exist for Hepadnaviridae and Caulimoviridae RTs, though cross-inhibition with HIV-1 RT drugs is observed.
Conclusions:
- Reverse transcription is a vital process for multiple virus families, with RTs being key targets for antiviral drug development.
- Further structural and biochemical characterization of RTs, especially from Hepadnaviridae and Caulimoviridae, is needed.
- Developing novel inhibitors, including ribonuclease H inhibitors, is crucial for combating viral infections like HIV.
Related Concept Videos
Viruses with RNA Genomes
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Retroviruses
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Subviral Agents

